Issue with use of SNOMED code for "pathologist evalution" to represent clinical staging

XMLWordPrintable

    • Type: Terminology
    • Resolution: Answered
    • Priority: Minor
    • Component/s: ValueSet
    • None
    • Barbara Katzenberg
    • 617 783 7964
    • Allscripts
    • Hide
      Thank you for your feedback. Per guidance statement for measures CMS140 and CMS141, the date of cancer diagnosis is defined as the date of pathologic diagnosis. The focus of these measures is to determine if patients with certain stages of cancer received appropriate treatment. When the measures were originally developed, they were not intended to evaluate how the cancer was staged. While cancer may be staged using findings from other sources, for these measures we intend to have a pathologic input to confirm diagnosis, and pathology results inform staging of the cancer. We plan to discuss this with the relevant specialty societies during the next round of updates to these measures to determine if there is an appropriate change to be made.
      Show
      Thank you for your feedback. Per guidance statement for measures CMS140 and CMS141, the date of cancer diagnosis is defined as the date of pathologic diagnosis. The focus of these measures is to determine if patients with certain stages of cancer received appropriate treatment. When the measures were originally developed, they were not intended to evaluate how the cancer was staged. While cancer may be staged using findings from other sources, for these measures we intend to have a pathologic input to confirm diagnosis, and pathology results inform staging of the cancer. We plan to discuss this with the relevant specialty societies during the next round of updates to these measures to determine if there is an appropriate change to be made.

      The value set for clinical staging includes only one code which has the description "pathologist evaluation." However our understanding is that clinical staging is an evaluation that incorporates findings from many sources (e.g., physical exam, imaging, diagnostic biopsies, etc). The staging is not performed by the pathologist, but rather by the surgeon or oncologist on the basis of all of the available evidence. Our client, a large oncology center, tells us that in some instances clinical staging may even occur without biopsy/cytology. We think the value set needs to be expanded or corrected to include SNOMED codes that represent clinical staging as opposed to the pathologist's contribution. In the interim, 1) should patients who had staging performed without biopsy be excluded from the measure and 2) should the time when pathologist's results are available be the point in time used for calculations; even if the actual staging occurred later.

            Assignee:
            Mathematica EC eCQM Team (Inactive)
            Reporter:
            Barbara Katzenberg (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            2 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: